Demystifying the role of postbiotics in inflammation mediated metabolic disorders: an updated review
Food Science and Biotechnology · 2026-02 · 35 (3) · 463-484
DOI: 10.1007/s10068-025-01952-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food Science and Biotechnology, online erschienen am 19.07.2025. Verfasst von Rohit Doke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Jaihind College of Pharmacy, Vadgaon Sahani, Pune, Maharashtra 412401 India. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Postbiotics, the metabolic byproducts of probiotic bacteria, have emerged as promising therapeutic agents for managing inflammation-mediated metabolic disorders. Postbiotics offer greater stability and standardization compared to probiotics, as they do not rely on live bacteria for their effects. These bioactive compounds including organic acids, peptides, short-chain fatty acids, enzymes, and exopolysaccharides play a crucial role in modulating immune responses, enhancing intestinal barrier function, and reducing chronic inflammation. Inflammation is a key factor in the development of metabolic disorders such as obesity, type 2 diabetes, metabolic syndrome, NAFLD, and cardiovascular diseases. By targeting multiple molecular pathways such as TLR4/NF-κB signaling, NLRP3 inflammasome activation, Treg/Th17 cell balance, AMPK pathway, MLCK inhibition, NLRC3-TRAF6 axis, AhR signaling, and STAT3-mediated mucin synthesis, postbiotics exert anti-inflammatory and gut-protective effects. These mechanisms include inhibition of pro-inflammatory cytokines, reduction of oxidative stress, improvement of tight junction integrity, and modulation of gut microbiota composition. Additionally, postbiotics have been shown to positively influence gut-brain signalling, contributing to better metabolic health and weight management. This review delves into the molecular mechanisms by which postbiotics regulate inflammatory pathways and metabolic processes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jaihind College of Pharmacy, Vadgaon Sahani, Pune, Maharashtra 412401 India.
- Dr. DY Patil College of Pharmacy Akurdi, Pune, Maharashtra 411044 India.
- TMV Lokmanya Tilak Institute of Pharmaceutical Sciences, Pune, Maharashtra 411037 India.
- Sandip Foundation's Sandip Institute of Pharmaceutical Sciences (SIPS), Nashik, Maharashtra 422213 India.
- Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200 Thailand.
- Office of Research Administration, Chiang Mai University, Chiang Mai, 50200 Thailand.
ORCID-Profile: Rohit Doke, Kalyani Chande, Shraddha Dingare, Kuldeep Vinchurkar, Sudarshan Singh
Zitieren
APA
Doke, R., Chande, K., Dingare, S., Vinchurkar, K., & Singh, S. (2026). Demystifying the role of postbiotics in inflammation mediated metabolic disorders: an updated review. Food Science and Biotechnology, 35(3), 463-484. https://doi.org/10.1007/s10068-025-01952-6
Vancouver
Doke R, Chande K, Dingare S, Vinchurkar K, Singh S. Demystifying the role of postbiotics in inflammation mediated metabolic disorders: an updated review. Food Science and Biotechnology. 2026;35(3):463-484. doi:10.1007/s10068-025-01952-6
BibTeX
@article{Doke2026,
author = {Doke, Rohit and Chande, Kalyani and Dingare, Shraddha and Vinchurkar, Kuldeep and Singh, Sudarshan},
title = {Demystifying the role of postbiotics in inflammation mediated metabolic disorders: an updated review},
journal = {Food Science and Biotechnology},
year = {2026},
volume = {35},
number = {3},
pages = {463--484},
doi = {10.1007/s10068-025-01952-6}
}
EUVIMED